Loading...
|
Please use this identifier to cite or link to this item:
http://ir.nhri.org.tw/handle/3990099045/10756
|
| Title: | Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease |
| Authors: | Zhao, W;Rasheed, A;Tikkanen, E;Lee, JJ;Butterworth, AS;Howson, JMM;Assimes, TL;Chowdhury, R;Orho-Melander, M;Damrauer, S;Small, A;Asma, S;Imamura, M;Yamauch, T;Chambers, JC;Chen, P;Sapkota, BR;Shah, N;Jabeen, S;Surendran, P;Lu, Y;Zhang, W;Imran, A;Abbas, S;Majeed, F;Trindade, K;Qamar, N;Mallick, NH;Yaqoob, Z;Saghir, T;Rizvi, SNH;Memon, A;Rasheed, SZ;Memon, FU;Mehmood, K;Ahmed, N;Qureshi, IH;Tanveer Us, S;Iqbal, W;Malik, U;Mehra, N;Kuo, JZ;Sheu, WH;Guo, X;Hsiung, CA;Juang, JJ;Taylor, KD;Hung, YJ;Lee, WJ;Quertermous, T;Lee, IT;Hsu, CC;Bottinger, EP;Ralhan, S;Teo, YY;Wang, TD;Alam, DS;Di Angelantonio, E;Epstein, S;Nielsen, SF;Nordestgaard, BG;Tybjaerg-Hansen, A;Young, R;Benn, M;Frikke-Schmidt, R;Kamstrup, PR;Jukema, JW;Sattar, N;Smit, R;Chung, RH;Liang, KW;Anand, S;Sanghera, DK;Ripatti, S;Loos, RJF;Kooner, JS;Tai, ES;Rotter, JI;Chen, YI;Frossard, P;Maeda, S;Kadowaki, T;Reilly, M;Pare, G;Melander, O;Salomaa, V;Rader, DJ;Danesh, J;Voight, BF;Saleheen, D |
| Contributors: | Institute of Population Health Sciences |
| Abstract: | To evaluate the shared genetic etiology of type 2 diabetes (T2D) and coronary heart disease (CHD), we conducted a genome-wide, multi-ancestry study of genetic variation for both diseases in up to 265,678 subjects for T2D and 260,365 subjects for CHD. We identify 16 previously unreported loci for T2D and 1 locus for CHD, including a new T2D association at a missense variant in HLA-DRB5 (odds ratio (OR) = 1.29). We show that genetically mediated increase in T2D risk also confers higher CHD risk. Joint T2D-CHD analysis identified eight variants-two of which are coding-where T2D and CHD associations appear to colocalize, including a new joint T2D-CHD association at the CCDC92 locus that also replicated for T2D. The variants associated with both outcomes implicate new pathways as well as targets of existing drugs, including icosapent ethyl and adipocyte fatty-acid-binding protein. |
| Date: | 2017-09-04 |
| Relation: | Nature Genetics. 2017 Sep 04;49(10):1450-1457. |
| Link to: | http://dx.doi.org/10.1038/ng.3943 |
| JIF/Ranking 2023: | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1061-4036&DestApp=IC2JCR |
| Cited Times(WOS): | https://www.webofscience.com/wos/woscc/full-record/WOS:000411855800008 |
| Cited Times(Scopus): | https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85030173238 |
| Appears in Collections: | [許志成] 期刊論文
[鍾仁華] 期刊論文
[熊昭] 期刊論文
|
Files in This Item:
| File |
Size | Format | |
|---|
| PUB28869590.pdf | 735Kb | Adobe PDF | 426 | View/Open |
|
All items in NHRI are protected by copyright, with all rights reserved.
|
